Burzynski Research Institute, Inc. (BZYR)
OTCMKTS · Delayed Price · Currency is USD
0.0230
0.00 (0.00%)
Mar 25, 2026, 9:30 AM EST
BZYR Market Cap
BZYR has a market cap or net worth of $2.98 million as of March 26, 2026. Its market cap has decreased by -37.43% in one year.
Market Cap
2.98M
Enterprise Value
2.98M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since April 28, 1997, BZYR's market cap has decreased from 16.41M to 2.98M, a decrease of -81.86%. That is a compound annual growth rate of -5.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 2.98M | 18.59% |
| Dec 29, 2025 | 2.51M | -38.39% |
| Dec 31, 2024 | 4.07M | -29.55% |
| Dec 29, 2023 | 5.78M | 70.28% |
| Dec 23, 2022 | 3.40M | 115.33% |
| Dec 31, 2021 | 1.58M | -33.33% |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GPL Holdings | 4.17M |
| Galera Therapeutics | 3.24M |
| Oncology Pharma | 3.09M |
| CASI Pharmaceuticals | 2.93M |
| Clearside Biomedical | 2.67M |
| Vaccinex | 2.38M |
| AXIM Biotechnologies | 2.37M |
| VitaSpring Biomedical | 2.30M |